Answers are grounded in this paper and cite their sources.
Analysis shows gastric acid assessment impacts therapy in MEN1-Zollinger-Ellison syndrome, indicating need for better guidelines.
Backgrounds and Aims No guidelines exist for gastric acid assessment (GAA) or endoscopic surveillance for patients with Multiple Endocrine Neoplasia Type 1-Zollinger-Ellison Syndrome (MEN1-ZES). We aimed to analyze how GAA via nasogastric tube (NGT) and esophagogastro-duodenoscopy (EGD) altered acid suppression therapy and identify pre-GAA factors associated with post-GAA medication changes to inform which patients benefit from GAAs and/or EGDs for surveillance.
No takes yet. Share an insight, caveat, or question.
Schueler et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: